FRANCHISE TRADE NOW OPEN AN ACCOUNT GLOBE E-KYC
Hot Pursuit
Prev Next
As on Aug 14, 2018 12:00 AM Your results on : Hot Pursuit    
Sun Pharma jumps after blockbuster Q1 result
14-Aug-2018 (15:28)
The result was announced during market hours today, 14 August 2018.

Meanwhile, the S&P BSE Sensex was up 222.59 points, or 0.59% to 37,867.49

On the BSE, 16.66 lakh shares were traded in the counter so far compared with average daily volumes of 4.36 lakh shares in the past two weeks. The stock had hit a high of Rs 608.10 and a low of Rs 560.40 so far during the day. The stock hit a 52-week high of Rs 608.55 on 12 February 2018. The stock hit a 52-week low of Rs 433.15 on 14 August 2017.

Sun Pharmaceutical Industries Q1 June 2018 consolidated net profit was Rs 983 crore, resulting net margin of 13.8%. Net profit for Q1 June 2017 was adversely impacted by settlement with certain plaintiffs related to the Modafinil antitrust litigation in the US, with the settlement amounting to Rs 951 crore. Excluding the impact of this settlement, adjusted net profit was up by 87% over Q1 June 2017. Sales / income from operations rose 16% to Rs 7139 crore in Q1 June 2018 over Q1 June 2017.

Sale of branded formulations in India for Q1 June 2018 was Rs 2152 crore, up 22% and accounting for 30% of total sales. Sales for Q1 last year were impacted by the implementation of GST in India. Sales in the US were US$ 380 million for the quarter, a growth of 8% over same period last year and accounted for 36% of total sales.

Sales in emerging markets were at US$ 195 million for Q1; a growth of 16% compared to the same quarter last year and accounted for 18% of total sales. Formulation sales in Rest of World (ROW) markets excluding US and Emerging Markets were US$ 107 million in Q1 June 2018, a decline of 7% from last year and accounting for approximately 10% of revenues.

Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries said that the company recorded good growth in all the major markets.

Sun Pharmaceutical Industries is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Vakrangee Ltd leads losers in 'A' group
14-Aug-2018 (15:00)
BKM Industries Ltd leads losers in 'B' group
14-Aug-2018 (14:45)
Volumes spurt at CARE Ratings Ltd counter
14-Aug-2018 (14:30)
Prism Johnson sizzles after securing coal requirement
14-Aug-2018 (13:51)
Cipla Ltd gains for third straight session
14-Aug-2018 (13:05)
Tata Elxsi Ltd soars 1.52%, rises for third straight session
14-Aug-2018 (13:05)
Mindtree Ltd spurts 2.66%, rises for third straight session
14-Aug-2018 (13:05)
Infibeam Incorporation Ltd up for fifth session
14-Aug-2018 (13:00)
Tata Consultancy Services Ltd spurts 1.09%, gains for fifth straight session
14-Aug-2018 (13:00)
Britannia Industries Ltd up for five straight sessions
14-Aug-2018 (13:00)
United Breweries Ltd up for fifth session
14-Aug-2018 (13:00)
Mahindra & Mahindra Ltd gains for fifth straight session
14-Aug-2018 (13:00)
Alpa Laboratories Ltd leads gainers in 'B' group
14-Aug-2018 (12:15)
Religare Enterprises Ltd leads gainers in 'A' group
14-Aug-2018 (12:00)
Volumes jump at Symphony Ltd counter
14-Aug-2018 (11:00)
Tata Steel shines after stellar Q1 result
14-Aug-2018 (10:49)
Asian Granito India drops after poor Q1 result
14-Aug-2018 (09:55)
Navneet Education spurts after buyback plan
14-Aug-2018 (09:39)
IT stocks head north on weak rupee
13-Aug-2018 (15:08)
Connect with us :   
Globe
About us
Our Services
Milestones
Memberships
Core Values
Investor Relations
Product & Services
Broking
Institutional Broking
PMS
Clearing Services
Distribution
Research
Depository
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
Back Office
Back Office
CMS
CMS-TM
KYC/KDC Status
Mutual Fund
CAMS
RMS Policy
Helpdesk
Download Forms
Useful Links
BSE
NSE
SEBI
RBI
MCX
NCDEX
Exchange Holidays
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD

Funds Payout Policy
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to
Investor_trading@globecapital.com /  igr@globecapital.com (For Trading)     globedp@globecapital.com (For DP)    Investor_pms@globecapital.com (For PMS)     
commigr@globecapital.com (For Commodities)
Equity SEBI Registration No INZ000177137. Exchange Registration Nos NSE : TM No. - 06637, Clearing No.- M50302 | BSE : Clearing No.- 3179 | MSEI : TM Code-1004, Clearing Member Code- 4 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No. INH100001187 | SEBI PMS Registration No. INP00000236
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by C-MOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions